Evidence map›Paper›PMID 34589480›Full record

ArticleFrontiers in cell and developmental biology2021

Differential Requirement of

Oscar A Peña, Alexandra Lubin, Jasmine Rowell, Yvette Hoade, Noreen Khokhar, Hanna Lemmik, Christopher Mahony, Phoebe Dace, Chianna Umamahesan, Elspeth M Payne

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. International journal of molecular sciences · 2023
    Article
  2. Zebrafish: a convenient tool for myelopoiesis research.Cell regeneration (London, England) · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Oscar A PeñaResearch Department of Haematology, Cancer Institute, University College London, London, United Kingdom.
Alexandra LubinResearch Department of Haematology, Cancer Institute, University College London, London, United Kingdom.
Jasmine RowellResearch Department of Haematology, Cancer Institute, University College London, London, United Kingdom.
Yvette HoadeResearch Department of Haematology, Cancer Institute, University College London, London, United Kingdom.
Noreen KhokharResearch Department of Haematology, Cancer Institute, University College London, London, United Kingdom.
Hanna LemmikResearch Department of Haematology, Cancer Institute, University College London, London, United Kingdom.
Christopher MahonyDepartment of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.
Phoebe DaceResearch Department of Haematology, Cancer Institute, University College London, London, United Kingdom.
Chianna UmamahesanResearch Department of Haematology, Cancer Institute, University College London, London, United Kingdom.
Elspeth M PayneResearch Department of Haematology, Cancer Institute, University College London, London, United Kingdom.
University College London · GBUniversity of Geneva · CH

Funding

Cancer Research UK 24873
6 · The paper itself

Abstract

Germline loss or mutation of one copy of the transcription factor GATA2 in humans leads to a range of clinical phenotypes affecting hematopoietic, lymphatic and vascular systems. GATA2 heterozygous mice show only a limited repertoire of the features observed in humans. Zebrafish have two copies of the Gata2 gene as a result of an additional round of ancestral whole genome duplication. These genes, Gata2a and Gata2b, show distinct but overlapping expression patterns, and between them, highlight a significantly broader range of the phenotypes observed in GATA2 deficient syndromes, than each one alone. In this manuscript, we use mutants for Gata2a and Gata2b to interrogate the effects on hematopoiesis of these two ohnologs, alone and in combination, during development in order to further define the role of GATA2 in developmental hematopoiesis. We define unique roles for each ohnolog at different stages of developmental myelopoiesis and for the emergence of hematopoietic stem and progenitor cells. These effects are not additive in the haploinsufficient state suggesting a redundancy between these two genes in hematopoietic stem and progenitor cells. Rescue studies additionally support that Gata2b can compensate for the effects of Gata2a loss. Finally we show that adults with loss of combined heterozygosity show defects in the myeloid compartment consistent with GATA2 loss in humans. These results build on existing knowledge from other models of GATA2 deficiency and refine our understanding of the early developmental effects of GATA2. In addition, these studies shed light on the complexity and potential structure-function relationships as well as sub-functionalization of Gata2 genes in the zebrafish model.

Indexed as

Gata2aGata2bhematopoiesismyelopoiesisstem cell

Identifiers

PMID34589480
PMCPMC8475954
OpenAlexW3201652819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.